MR. PHILIP KLEIN

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$867K

Filings

Unique Clients

Active Period

2017–2025

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2025	—	2	2
2024	$110,000	8	2
2023	$110,000	8	2
2022	$125,000	9	2
2021	$110,000	8	2
2020	$111,664	8	2
2019	$120,000	8	2
2018	$115,500	10	3
2017	$65,000	7	2

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
RB	$465,000	33	2017–2025
CLOROX CORPORATION	$357,164	29	2018–2025
CROPLIFE AMERICA FOR THE PRIA COALITION	$45,000	6	2017–2018

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Environmental Protection Agency (EPA)	44
Health & Human Services, Dept of (HHS)	17
Food & Drug Administration (FDA)	16

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Chemicals/Chemical Industry	Chemicals/Chemical Industry	41
Agriculture	Agriculture	33
Manufacturing	Manufacturing	1
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5978118th Congress

Cleaning Product Ingredient Communication Act

2024 · fourth_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

cosmetic legislation - naturals definition HR 5978 - Cleaning Products

Client expense: — · Firm income: $12,500

Matched citations: HR 5978

H.R. 5978118th Congress

Cleaning Product Ingredient Communication Act

2024 · third_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

cosmetic legislation - naturals definition HR 5978 - Cleaning Products

Client expense: — · Firm income: $12,500

Matched citations: HR 5978

H.R. 5978118th Congress

Cleaning Product Ingredient Communication Act

2024 · second_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

cosmetic legislation - naturals definition HR 5978 - Cleaning Products

Client expense: — · Firm income: $12,500

Matched citations: HR 5978

H.R. 5978118th Congress

Cleaning Product Ingredient Communication Act

2024 · first_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

cosmetic legislation - naturals definition HR 5978 - Cleaning Products

Client expense: — · Firm income: $12,500

Matched citations: HR 5978

Show 21 more cited filings

H.R. 5978118th Congress

Cleaning Product Ingredient Communication Act

2023 · fourth_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

cosmetic legislation - naturals definition HR 5978 - Cleaning Products

Client expense: — · Firm income: $12,500

Matched citations: HR 5978

H.R. 5279116th Congress

Cosmetic Safety Enhancement Act of 2019

2020 · fourth_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals) House appopriations (support report language on Naturals encouraging FDA to define naturals)

Client expense: — · Firm income: $12,500

Matched citations: HR 5279

S. 726116th Congress

Personal Care Products Safety Act

2020 · fourth_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals) House appopriations (support report language on Naturals encouraging FDA to define naturals)

Client expense: — · Firm income: $12,500

Matched citations: S726

H.R. 5279116th Congress

Cosmetic Safety Enhancement Act of 2019

2020 · third_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals) House appopriations (support report language on Naturals encouraging FDA to define naturals)

Client expense: — · Firm income: $12,500

Matched citations: HR 5279

S. 726116th Congress

Personal Care Products Safety Act

2020 · third_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals) House appopriations (support report language on Naturals encouraging FDA to define naturals)

Client expense: — · Firm income: $12,500

Matched citations: S726

H.R. 5279116th Congress

Cosmetic Safety Enhancement Act of 2019

2020 · second_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals)

Client expense: — · Firm income: $13,332

Matched citations: HR 5279

S. 726116th Congress

Personal Care Products Safety Act

2020 · second_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals)

Client expense: — · Firm income: $13,332

Matched citations: S726

H.R. 5279116th Congress

Cosmetic Safety Enhancement Act of 2019

2020 · first_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals)

Client expense: — · Firm income: $13,332

Matched citations: HR 5279

S. 726116th Congress

Personal Care Products Safety Act

2020 · first_quarter · Client: CLOROX CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Pesticide Registration Improvement Act ingredient disclosure antimicrobials support of HR 5279 - Cosmetic Safety Enhancement act (encouraging FDA to define of naturals) Support of S726 _ Cosmetic Safety Enhancement act (encouraging FDA ti define naturals)

Client expense: — · Firm income: $13,332

Matched citations: S726

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · fourth_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049 and antimicrobial issues (including provisions in Farm Bill)

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · fourth_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049, Safer Choice, antimicrobial issues Farm Bill

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · third_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049, Safer Choice, antimicrobial issues Farm Bill

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · third_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049 and antimicrobial issues (including provisions in Farm Bill)

Client expense: — · Firm income: $15,000

Matched citations: S1049

H.R. 1029115th Congress

Pesticide Registration Improvement Extension Act of 2018

2018 · first_quarter · Client: CROPLIFE AMERICA FOR THE PRIA COALITION

Open original LDA filing ↗

Cited source text and reported amounts

HR 1029 and the Senate amendment to HR 1029 - the pesticide enhancement improvement act.

Client expense: — · Firm income: $5,000

Matched citations: HR 1029

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · second_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049, Safer Choice, antimicrobial issues

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · second_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049 and antimicrobial issues

Client expense: — · Firm income: $15,000

Matched citations: S1049

H.R. 1029115th Congress

Pesticide Registration Improvement Extension Act of 2018

2018 · first_quarter · Client: CROPLIFE AMERICA FOR THE PRIA COALITION

Open original LDA filing ↗

Cited source text and reported amounts

HR 1029 and the Senate amendment to HR 1029 - the pesticide enhancement improvement act.

Client expense: — · Firm income: $5,000

Matched citations: HR 1029

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · first_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049, Safer Choice, antimicrobial issues

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2018 · first_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049 and antimicrobial issues

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2017 · fourth_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049, Safer Choice, antimicrobial issues

Client expense: — · Firm income: $15,000

Matched citations: S1049

S. 1049115th Congress

Opioid Addiction Risk Transparency Act

2017 · fourth_quarter · Client: RB

Open original LDA filing ↗

Cited source text and reported amounts

PRIA S1049 and antimicrobial issues

Client expense: — · Firm income: $15,000

Matched citations: S1049

Source: Senate LDA

MR. PHILIP KLEIN — Lobbying Disclosure | Poliscope